Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;28(10):1400.
doi: 10.1016/j.cmi.2022.04.021. Epub 2022 May 10.

Re: Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2 by Massalha et al

Affiliations
Comment

Re: Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2 by Massalha et al

Guangting Zeng. Clin Microbiol Infect. 2022 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Ellington S., Strid P., Tong V.T., Woodworth K., Galang R.R., Zambrano L.D., et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:769–775. - PMC - PubMed
    1. Massalha M., Yefet E., Rozenberg O., Soltsman S., Hasanein J., Smolkin T., et al. Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2 - a prospective multicenter cohort study. Clin Microbiol Infect. 2022 [Epub ahead of print] - PMC - PubMed
    1. Garcia-Flores V., Romero R., Xu Y., Theis K.R., Arenas-Hernandez M., Miller D., et al. Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nat Commun. 2022;13:320. - PMC - PubMed
    1. Pique-Regi R., Romero R., Tarca A.L., Luca F., Xu Y., Alazizi A., et al. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? Elife. 2020;9 - PMC - PubMed
    1. Shuai H., Chan J.F., Hu B., Chai Y., Yuen T.T., Yin F., et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529. Omicron Nat. 2022;603:693–699. - PubMed

LinkOut - more resources